The sequelae of herpes zoster

被引:86
作者
Galil, K
Choo, PW
Donahue, JG
Platt, R
机构
[1] BRIGHAM & WOMENS HOSP,CHANNING LAB,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,DEPT AMBULATORY CARE & PREVENT,BOSTON,MA 02115
[3] HARVARD PILGRIM HLTH CARE,BOSTON,MA 02115
关键词
D O I
10.1001/archinte.157.11.1209
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The last 40 years was a period during which the incidence of herpes tester appears to have increased substantially. Objective: To determine whether the risk of complications of herpes tester has changed during the last 40 years. Methods: The automated medical records of a health maintenance organization were screened for diagnosis codes suggesting herpes tester and potentially complicated cases of tester. The predictive value of a herpes zoster diagnosis was calculated from sampling full-text records. Records of all patients with codes suggesting complications were reviewed in full. Results: Of 859 individuals with herpes tester who met the eligibility criteria, 101 were identified who experienced at least I complication, corresponding to a 60-day risk of 12%. Corrected for the sensitivity of the complication-finding strategy, the risk estimate was 14%. Risk increased markedly with age, with those older than 64 years having more than 6 times the risk of complications of those younger than 25 years (odds ratio, 8.3; 95% confidence interval, 2.5-29.3). Trigeminal distribution of rash and the presence of certain conditions associated with immune compromise appeared to increase risk. Conclusions: The apparent increase in the incidence of herpes tester was not accompanied by a change in the risk of specific or overall complications in a population-based sample. Advanced age and other conditions associated with waning cellular immunity may confer an increased risk of experiencing a complicated course of herpes zoster.
引用
收藏
页码:1209 / 1213
页数:5
相关论文
共 7 条
[1]   COSTAR - COMPUTER-BASED MEDICAL INFORMATION-SYSTEM FOR AMBULATORY CARE [J].
BARNETT, GO ;
JUSTICE, NS ;
SOMAND, ME ;
ADAMS, JB ;
WAXMAN, BD ;
BEAMAN, PD ;
PARENT, MS ;
VANDEUSEN, FR ;
GREENLIE, JK .
PROCEEDINGS OF THE IEEE, 1979, 67 (09) :1226-1237
[2]   Risk factors for postherpetic neuralgia [J].
Choo, PW ;
Galil, K ;
Donahue, JG ;
Walker, AM ;
Spiegelman, D ;
Platt, R .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (11) :1217-1224
[3]   THE INCIDENCE OF HERPES-ZOSTER [J].
DONAHUE, JG ;
CHOO, PW ;
MANSON, JE ;
PLATT, R .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (15) :1605-1609
[4]  
PLATT R, 1994, PHARMACOEPIDEM DR S, P278
[5]   POPULATION-BASED STUDY OF HERPES-ZOSTER AND ITS SEQUELAE [J].
RAGOZZINO, MW ;
MELTON, LJ ;
KURLAND, LT ;
CHU, CP ;
PERRY, HO .
MEDICINE, 1982, 61 (05) :310-316
[6]   GERIATRIC HERPES ZOSTER [J].
ROGERS, RS ;
TINDALL, JP .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1971, 19 (06) :495-&
[7]   VARICELLA-ZOSTER VIRUS-INFECTIONS - BIOLOGY, NATURAL-HISTORY, TREATMENT, AND PREVENTION [J].
STRAUS, SE ;
OSTROVE, JM ;
INCHAUSPE, G ;
FELSER, JM ;
FREIFELD, A ;
CROEN, KD ;
SAWYER, MH .
ANNALS OF INTERNAL MEDICINE, 1988, 108 (02) :221-237